References
- Basu S, Shivhare US, Raghavan GSV. (2007). Time dependent rheological characteristics of pineapple jam. Int J Food Eng 3 (3)
- Bhatia A, Raza K, Singh B, Katare OP. (2009). Phospholipid-based formulation with improved attributes of coal tar. J Cosmet Dermatol 8:282–8
- Bhatia A, Singh B, Raza K, et al. (2013). Tamoxifen-loaded lecithin organogel (LO) for topical application: Development, optimization and characterization. Int J Pharm 444:47–59
- Brodin A, Nyqvist-Mayer A, Wadsten T, et al. (1984). Phase diagram and aqueous solubility of the lidocaine-prilocaine binary system. J Pharm Sci 73:481–4
- Daniel WW, Cross CL. (2013). Biostatistics: a foundation for analysis in the health sciences (Wiley Series in Probability and Statistics). Hoboken, NJ: John Wiley & Sons Inc
- DeCou JM, Abrams RS, Hammond JH, et al. (1999). Iontophoresis: a needle-free, electrical system of local anesthesia delivery for pediatric surgical office procedures. J Pediatr Surg 34:946–9
- Dreher F, Walde P, Walther P, Wehrli E. (1997). Interaction of a lecithin microemulsion gel with human stratum corneum and its effect on transdermal transport. J Control Release 45:131–40
- Kearns GL, Heacook J, Daly SJ, et al. (2003). Percutaneous lidocaine administration via a new iontophoresis system in children: tolerability and absence of systemic bioavailability. Pediatrics 112:578–82
- Kogan A, Garti N. (2006). Microemulsions as transdermal drug delivery vehicles. Adv Colloid Interface Sci 123–126:369–85
- Kreilgaard M. (2002). Influence of microemulsions on cutaneous drug delivery. Adv Drug Deliv Rev 54:S77–98
- Kreilgaard M, Pedersen EJ, Jaroszewski JW. (2000). nmR characterisation and transdermal drug delivery potential of microemulsion systems. J Control Release 69:421–33
- Lee PJ, Langer R, Shastri VP. (2003). Novel microemulsion enhancer formulation for simultaneous transdermal delivery of hydrophilic and hydrophobic drugs. Pharm Res 20:264–9
- Lionberger RA, Lee SL, Lee L, et al. (2008). Quality by design: concepts for ANDAs. AAPS J 10:268–76
- Naik A, Kalia YN, Guy RH. (2000). Transdermal drug delivery: overcoming the skin's barrier function. Pharm Sci Technolo Today 3:318–26
- Paolino D, Ventura CA, Nisticò S, et al. (2002). Lecithin microemulsions for the topical administration of ketoprofen: percutaneous adsorption through human skin and in vivo human skin tolerability. Int J Pharm 244:21–31
- Peltola S, Saarinen–Savolainen P, Kiesvaara J, et al. (2003). Microemulsions for topical delivery of estradiol. Int J Pharm 254:99–07
- Raza K, Negi P, Takyar S, et al. (2011). Novel dithranol phospholipid microemulsion for topical application: development, characterization and percutaneous absorption studies. J Microencapsul 28:190–9
- Raza K, Singh B, Lohan S, et al. (2013). Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity. Int J Pharm 456:65–72
- Raza K, Singh B, Mahajan A, et al. (2011). Design and evaluation of flexible membrane vesicles (FMVs) for enhanced topical delivery of capsaicin. J Drug Target 19:293–302
- Russell SC, Doyle E. (1997). A risk-benefit assessment of topical percutaneous local anaesthetics in children. Drug Saf 16:279–87
- Scherlund M, Malmsten M, Holmqvist P, Brodin A. (2000). Thermosetting microemulsions and mixed micellar solutions as drug delivery systems for periodontal anesthesia. Int J Pharm 194:103–16
- Shakeel F, Baboota S, Ahuja A, et al. (2007). Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS PharmSciTech 8: E1–E9
- Shin SC, Cho CW, Yang KH. (2004). Development of lidocaine gels for enhanced local anesthetic action. Int J Pharm 287:73–8
- Shinoda K, Kaneko T. (1988). Characteristic properties of lecithin as a surfactant. J Disp Sci Tech 9:555–9
- Singh B, Dahiya M, Saharan V, Ahuja N. (2005). Optimizing drug delivery systems using systematic “design of experiments.” Part II: retrospect and prospects. Crit Rev Ther Drug Carrier Syst 22:215–94
- Singh B, Kapil R, Nandi M, Ahuja N. (2011). Developing oral drug delivery systems using formulation by design: vital precepts, retrospect and prospects. Expert Opin Drug Deliv 8:1341–60
- Singh B, Kumar R, Ahuja N. (2005). Optimizing drug delivery systems using systematic “design of experiments.” Part I: fundamental aspects. Crit Rev Ther Drug Carrier Syst 22:27–105
- Sintov AC, Shapiro L. (2004). New microemulsion vehicle facilitates percutaneous penetration in vitro and cutaneous drug bioavailability in vivo. J Control Release 95:173–83
- Sobanko JF, Miller CJ, Alster TS. (2012). Topical anesthetics for dermatologic procedures: a review. Dermatol Surg 38:709–21
- Tadicherla S, Berman B. (2006). Percutaneous dermal drug delivery for local pain control. Ther Clin Risk Manag 2:99–113
- Tadros T. (2006). Principles of emulsion stabilization with special reference to polymeric surfactants. J Cosmet Sci 57:153–69
- Welin-Berger K, Neelissen J, Bergenstahl B. (2001). In vitro permeation profile of a local anaesthetic compound from topical formulations with different rheological behavior – verified by in vivo efficacy data. Eur J Pharm Sci 14:229–36
- Williams AC, Barry BW. (2004). Penetration enhancers. Adv Drug Deliv Rev 56:603–18
- Yokomizo Y, Sagitani H. (1996). Effects of phospholipids on the in vitro percutaneous penetration of prednisolone and analysis of mechanism by using attenuated total reflectance – Fourier transform infrared spectroscopy. J Pharm Sci. 85:1220–6